ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

3D Systems (DDD) Stock Trades Up, Here Is Why

DDD Cover Image

What Happened?

Shares of 3D printing company 3D Systems (NYSE: DDD) jumped 6.5% in the afternoon session after the company announced significant momentum and strong growth projections for its Aerospace & Defense (A&D) business. 

3D Systems projected that its A&D segment would become its largest and fastest-growing industrial business in 2026. The company stated the division's revenue grew over 15% in 2025 and was forecast to accelerate to more than 20% growth in 2026. This expansion was driven by increasing demand for U.S.-based manufacturing, supported by recent provisions in the National Defense Authorization Act that restrict foreign-sourced 3D printing systems for Department of Defense programs. To support this growth, the company also announced it was expanding its facility in Littleton, Colorado.

Is now the time to buy 3D Systems? Access our full analysis report here.

What Is The Market Telling Us

3D Systems’s shares are extremely volatile and have had 67 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 21 days ago when the stock gained 3.9% as the company announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance to expand its VSP Orthopedics platform to include skeletally mature adolescents. 

This approval extended the use of its virtual surgical planning platform, which was previously limited to adults. The clearance streamlined the treatment process for younger patients by removing the need for case-by-case compassionate-use approvals and hospital reviews. This change turned what were off-label uses into standard, reimbursable procedures. The expansion targeted an underserved patient group, including over 1,200 patients under age 20 diagnosed with bone cancer annually in the United States. Investors reacted positively as the news supported the company's goal for double-digit growth in its Healthcare segment.

3D Systems is up 7.8% since the beginning of the year, but at $2.00 per share, it is still trading 57.7% below its 52-week high of $4.72 from February 2025. Investors who bought $1,000 worth of 3D Systems’s shares 5 years ago would now be looking at an investment worth $183.20.

While Wall Street chases Nvidia at all-time highs, an under-the-radar semiconductor supplier is dominating a critical AI component these giants can’t build without. Click here to access our full research report.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  236.71
-5.89 (-2.43%)
AAPL  260.01
-1.04 (-0.40%)
AMD  223.59
+2.62 (1.19%)
BAC  52.48
-2.06 (-3.78%)
GOOG  336.31
-0.12 (-0.04%)
META  615.58
-15.51 (-2.46%)
MSFT  459.53
-11.14 (-2.37%)
NVDA  183.16
-2.65 (-1.43%)
ORCL  193.61
-8.68 (-4.29%)
TSLA  439.29
-7.91 (-1.77%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.